Copaxone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
Condition:   Multiple SclerosisIntervention:   Sponsor:   Rutgers, The State University of New JerseyActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2013 Category: Research Source Type: clinical trials

Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
Condition:   Multiple SclerosisIntervention:   Sponsor:   Rutgers, The State University of New JerseyRecruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2013 Category: Research Source Type: clinical trials

Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
Condition:   Multiple SclerosisIntervention:   Sponsor:   Rutgers, The State University of New JerseyRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2013 Category: Research Source Type: clinical trials

Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells
Condition:   Multiple SclerosisIntervention:   Sponsor:   Rutgers, The State University of New JerseyRecruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2013 Category: Research Source Type: clinical trials